FMP
Dec 09, 2025
Campbell Soup Company, listed as NASDAQ:CPB, is a well-known player in the food industry, primarily recognized for its canned soups and ready-to-eat meals. The company competes with other food giants like General Mills and Kraft Heinz. On December 9, 2025, CPB reported earnings per share of $0.77, surpassing the estimated $0.73, showcasing its strong financial performance.
The company achieved a revenue of approximately $2.68 billion, exceeding the estimated $2.66 billion. This success is driven by strong demand for its products, as consumers opt to dine at home more frequently due to economic uncertainty. This trend has positively impacted Campbell's sales, as highlighted by the company's first-quarter results for fiscal 2026.
CEO Mick Beekhuizen emphasized the effectiveness of Campbell's in-market execution amidst a challenging operating environment. Despite these challenges, the company has reaffirmed its guidance for the full fiscal year 2026, indicating confidence in its strategic direction. This confidence is further supported by the company's financial metrics.
Campbell's P/E ratio of approximately 14.87 suggests a reasonable valuation compared to its earnings. The price-to-sales ratio of about 0.87 indicates the market's valuation of its sales. The enterprise value to sales ratio of around 1.56 reflects the company's total valuation in relation to its sales, while the enterprise value to operating cash flow ratio of approximately 14.03 provides insight into its cash flow efficiency.
With an earnings yield of 6.72%, Campbell offers a return on investment relative to its share price. However, the debt-to-equity ratio of 1.85 suggests a higher reliance on debt financing compared to equity. The current ratio of 0.77 indicates the company's ability to cover its short-term liabilities with its short-term assets, highlighting areas for potential improvement in liquidity management.
Kymera Therapeutics (NASDAQ: KYMR) is a clinical-stage biopharmaceutical company focused on developing degrader medicine...
Phreesia, Inc. (NYSE:PHR) is a healthcare technology company that provides a patient intake management platform. The pla...